// Generated by http://www.fidelitybiosciences.com/news/news_highlights.cgi on Thu Sep 9 07:34:45 2010 document.write('
09.01.2010
Pfizer to Acquire FoldRx Pharmaceuticals
08.25.2010
ViewRay Secures Series C Financing
07.15.2010
WuXi PharmaTech Announces Preliminary Second-Quarter 2010 Financial Highlights and Increases Full-Year 2010 Financial Guidance
07.14.2010
ENVIVO PHARMACEUTICALS ANNOUNCES SIGNIFICANT RESULTS FROM GSM TRANSGENIC MOUSE MODEL FOR ALZHEIMER’S DISEASE
07.12.2010
Accuri Cytometers Completes $6 Million Series E Financing
06.30.2010
Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders
06.28.2010
Ikano Therapeutics in Exclusive Global Licensing Agreement for ITI-111
06.23.2010
Mersana Initiates Phase 1 Clinical Trial for XMT-1107 in Oncology
06.17.2010
ARIKACE™ DEMONSTRATES SUSTAINED BENEFIT IN THE TREATMENT OF CYSTIC FIBROSIS PATIENTS WHO HAVE PSEUDOMONAS LUNG INFECTIONS
06.15.2010
FoldRx Pharmaceuticals Secures $29 Million Financing
');